Cipla is a global generic and complex pharmaceutical company that manufactures and sells branded and generic formulations, inhalers, peptide injectables, and APIs across India, North America, Africa, and emerging markets. The US respiratory launch wave—gVentolin ramping, gAdvair awaiting approval—is the engine, but the last print cooled. Price already banks it all.